Search Results for 'Trastuzumab'

Trastuzumab published presentations and documents on DocSlides.

Eribulin Mesylate + Trastuzumab

Eribulin Mesylate + Trastuzumab

by easyho

as First-Line Therapy for Locally Recurrent or . M...

Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín

Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín

by delcy

Trastuzumab-emtansine. : A . very. . nice. . poi...

Module 9: HER2-Positive and Triple-Negative BC

Module 9: HER2-Positive and Triple-Negative BC

by unita

Percent with Patients. Number of Patients (Median)...

Her2 + Breast Cancer Laura

Her2 + Breast Cancer Laura

by ximena

Bidstrup. Mrs B is a 49 . yo. woman who attended ...

Risk of Heart Failure in Breast Cancer Patients After

Risk of Heart Failure in Breast Cancer Patients After

by sophia2

Anthracycline. and . Trastuzumab. Treatment: A R...

Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use

Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use

by gelbero

Sara A. Hurvitz, MD, FACP. Professor of Medicine. ...

Breast Cancer in Older Patients

Breast Cancer in Older Patients

by ButterflyKisses

Key Issues. Etienne GC . Brain. , MD . PhD. Instit...

Cost Impact Of Biosimiliars in Oncology

Cost Impact Of Biosimiliars in Oncology

by williams

Mansoor A Khan, BS, MS, BCOP. Senior Clinical Phar...

Budget impact and cost-effectiveness of oncology

Budget impact and cost-effectiveness of oncology

by roxanne

biosimilars. Prof. dr. Steven Simoens. Health econ...

Part B Medical Drugs Requiring StepTherapy

Part B Medical Drugs Requiring StepTherapy

by natalie

Drug subject to Step Therapy BRAND NAME GENERIC NA...

Part B Medical Drugs Requiring Step

Part B Medical Drugs Requiring Step

by udeline

-TherapyDrug subject to Step TherapyTry these Opti...

Module 9: HER2-Positive and

Module 9: HER2-Positive and

by norah

Triple-Negative Breast Cancer. Jamie Carroll, APRN...

Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings

Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings

by marina-yarberry

Management of HER2 Over-Expressed Breast Cancer i...

Neoadjuvant Target Therapy in Her-2 Positive Breast Cancer

Neoadjuvant Target Therapy in Her-2 Positive Breast Cancer

by faustina-dinatale

Dr. . Khaled Abulkhair, PhD. Medical Oncology SCE...

by tawny-fly

Gradishar. . MD, FACP. Betsy . Bramsen. Profess...

Metastatic HER2-Positive Breast Cancer: Treatment Selection

Metastatic HER2-Positive Breast Cancer: Treatment Selection

by test

First . Line and Beyond. Moderator:. Joseph Gligo...

by danika-pritchard

patients . i.e. Patient relapses during or within...

Metastatic triple-positive

Metastatic triple-positive

by marcos147

breast. . cancer. . needs. . different. . ther...

GIULIANA D’AURIA UOC Oncologia ASL Roma 2

GIULIANA D’AURIA UOC Oncologia ASL Roma 2

by hadley

Osp. . Pertini-S.Eugenio-CTO. Therapeutic. . app...

Advanced Breast Cancer 31 year old female px severe pain right UL ‘burning’ pain

Advanced Breast Cancer 31 year old female px severe pain right UL ‘burning’ pain

by margaret

Background of lower back pain for 3/12 . No past ...

Antibody–Drug Conjugates

Antibody–Drug Conjugates

by wang

in Development for . Breast Cancer. Sara A. Hurvit...

Antibody–Drug Conjugates in Development for Non-

Antibody–Drug Conjugates in Development for Non-

by elizabeth

s. mall Cell . Lung Cancer. , Gastric Cancer, and ...

CoclusteringofErbB1andErbB2RevealedbyFRETSensitizedAcceptorBleachingg

CoclusteringofErbB1andErbB2RevealedbyFRETSensitizedAcceptorBleachingg

by cora

SubmittedDecember10,2009,andacceptedforpublication...

HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ

HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ

by carny

Heather M. Gage, MD, Avanti . Rangnekar. , Robert ...

DRUG NAMES AND MEDICATION ERRORS

DRUG NAMES AND MEDICATION ERRORS

by freya

1. DRUG NAMES. Chemical name. Development name use...

Dawid Sigorski, Ph.D .

Dawid Sigorski, Ph.D .

by morgan

Department. of . oncology. . UWM. Epidemiology. ...

Updates in the Treatment of Breast cancer

Updates in the Treatment of Breast cancer

by alexa-scheidler

Mohammad . Jahanzeb. , MD, FACP. Professor of Cli...

Systemic Therapy for Breast Cancer

Systemic Therapy for Breast Cancer

by natalia-silvester

Adjuvant or Neoadjuvant. Agustin A Garcia, MD, MM...

ID DB06366 CATEGORY

ID DB06366 CATEGORY

by luanne-stotts

Monoclonal antibodies . PERTUZUMAB . 148 . kDa. ...

update in metastatic breast c

update in metastatic breast c

by min-jolicoeur

. Dr.Mina. . Tajvidi. Radiation . oncologist. ...

Breast Cancer Highlights From San Antonio

Breast Cancer Highlights From San Antonio

by tatyana-admore

Joyce O'Shaughnessy, MD. Kimberly Blackwell, MD. ...

Managing Breast Cancer in the Genomic Era

Managing Breast Cancer in the Genomic Era

by alida-meadow

Leisha. A. . Emens. , M.D., . Ph.D. Associate Pr...

by danika-pritchard

&. monitoring of chemotherapy. Cardiovascular...

New Therapies for Metastatic Breast Cancer

New Therapies for Metastatic Breast Cancer

by alexa-scheidler

Sigrun Hallmeyer, MD. Oncology Specialists, SC. D...